Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer

被引:12
|
作者
An, Ho Jung [1 ]
Jeon, Hyun Jeong [2 ]
Chun, Sang Hoon [3 ]
Jung, Hyun Ae [4 ]
Ahn, Hee Kyung [5 ]
Lee, Kyung Hee [6 ]
Kim, Min-ho [7 ]
Kim, Ju Hee [8 ]
Cheon, Jaekyung [8 ]
Kim, JinShil [9 ]
Koh, Su-Jin [8 ]
机构
[1] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Med Oncol, Suwon, South Korea
[2] Seoul Med Ctr, Dept Internal Med, Seoul, South Korea
[3] Catholic Univ Korea, Bucheon St Marys Hosp, Coll Med, Div Med Oncol,Dept Internal Med, Bucheon, South Korea
[4] Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Dept Internal Med, Hwaseong, South Korea
[5] Cachou Univ, Dept Internal Med, Div Med Oncol, Gil Med Ctr, Incheon, South Korea
[6] Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea
[7] Ewha Womans Univ, Ewha Inst Convergence Med, Mokdong Hosp, Seoul, South Korea
[8] Ulsan Univ, Ulsan Univ Hosp, Dept Hematol & Oncol, Coll Med, 877 Bangeojinsunhwando Ro, Ulsan 4403, South Korea
[9] Gachon Univ, Coll Nursing, Incheon, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2019年 / 51卷 / 04期
关键词
Physician Orders for Life-Sustaining Treatment; Terminal cancer; Feasibility; ADVANCE DIRECTIVES; SERIOUSLY ILL; END; CARE; ATTITUDES; BARRIERS; DECISIONS; EFFICACY; FAMILIES; DISEASE;
D O I
10.4143/crt.2019.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Physician Orders for Life-Sustaining Treatment (POLST) form is a legal document for terminally ill patients to make medical decisions with physicians near the end-of-life. A multicenter prospective study was conducted to evaluate the feasibility of POLST administration in actual oncological practice. Materials and Methods Patients with terminal cancer, age >= 20 years, and capable of communicating were eligible. The primary endpoint was the completion rate of POLST. Data about physicians' or patients' barriers were also collected. Results From June to December 2017, 336 patients from seven hospitals were eligible. Median patient age was 66 years (range, 20 to 94 years); 52.7% were male; and 60.4% had poor performance status. Primary cancer sites were hepato-pancreato-biliary (26.2%), lung (23.2%), and gastrointestinal (19.9%). Expected survival duration was 10.6 +/- 7.3 weeks, with 41.2% receiving hospice care, 37.9% showing progression after cancer treatment, and the remaining patients were under active treatment (15.8%) or initially diagnosed with terminal cancer (5.1%). POLST forms were introduced to 60.1% of patients, and 31.3% signed the form. Physicians' barriers were reluctance of family (49.7%), lack of rapport (44.8%), patients' denial of prognosis (34.3%), lack of time (22.7%), guilty feelings (21.5%), and uncertainty about either prognosis (21.0%) or the right time to discuss POLST (16.6%). The patients' barriers were the lack of knowledge/understanding of POLST (65.1%), emotional discomfort (63.5%), difficulty in decision-making (66.7%), or denial of prognosis (14.3%). Conclusion One-third of patients completed POLST forms, and various barriers were identified. To overcome such barriers, social engagement, education, and systematic support might be necessary.
引用
收藏
页码:1632 / 1638
页数:7
相关论文
共 50 条
  • [1] A feasibility study of the Physician Orders for Life-Sustaining Treatment for patients with terminal cancer.
    Koh, Su-Jin
    An, Ho Jung
    Jun, Hyun Jung
    Chun, Sang Hoon
    Lee, Kyung Hee
    Ahn, Hee Kyung
    Jung, Hyun Ae
    Hee, Kim Ju
    Kim, Min-Ho
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (34)
  • [2] Multicenter feasibility study of physician orders for life-sustaining treatment (POLST) for terminal cancer patients
    An, H. J.
    Jeon, H. J.
    Cheon, J.
    Chun, S. H.
    Jung, H. A.
    Ahn, H. K.
    Lee, K. H.
    Kim, M-H.
    Kim, J. H.
    Kim, S.
    Koh, S-J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [3] The Problems With Physician Orders for Life-Sustaining Treatment
    Moore, Kendra A.
    Rubin, Emily B.
    Halpern, Scott D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (03): : 259 - 260
  • [4] The Quality of Physician Orders for Life-Sustaining Treatment Decisions: A Pilot Study
    Hickman, Susan E.
    Hammes, Bernard J.
    Torke, Alexia M.
    Sudore, Rebecca L.
    Sachs, Greg A.
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (02) : 155 - 162
  • [5] Association of Physician Orders for Life-Sustaining Treatment With Inpatient Antimicrobial Use at End of Life in Patients With Cancer
    Kates, Olivia S.
    Krantz, Elizabeth M.
    Lee, Juhye
    Klaassen, John
    Morris, Jessica
    Mezheritsky, Irina
    Sweet, Ania
    Tverdek, Frank
    Loggers, Elizabeth T.
    Pergam, Steven A.
    Liu, Catherine
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
  • [6] UTILIZATION OF PHYSICIAN'S ORDERS FOR LIFE-SUSTAINING TREATMENT (POLST) PROGRAM AMONG CANCER PATIENTS
    Tark, Aluem
    Bressler, Toby
    [J]. ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [7] Physician Orders for Life-Sustaining Treatment and Limiting Overtreatment at the End of Life
    Truog, Robert D.
    Fried, Terri R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (10): : 934 - 935
  • [8] Surrogate Preferences on the Physician Orders for Life-Sustaining Treatment Form
    Chen, Elizabeth E.
    Pu, Charles T.
    Bernacki, Rachelle E.
    Ragland, Julia
    Schwartz, Jonathon H.
    Mutchler, Jan E.
    [J]. GERONTOLOGIST, 2019, 59 (05): : 811 - 821
  • [9] Assessing Evidence for Physician Orders for Life-Sustaining Treatment Programs
    Tolle, Susan W.
    Moss, Alvin H.
    Hickman, Susan E.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (22): : 2471 - 2472
  • [10] RE: THE OREGON PHYSICIAN ORDERS FOR LIFE-SUSTAINING TREATMENT REGISTRY
    Mirarchi, Ferdinando
    Cammarata, Christopher
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2015, 48 (02): : 215 - 217